Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans

World Journal of Gastroenterology

Volumn 19, Issue 38, 2013, Pages 6453-6457

  Choi, Dae Hee ^a   Lee, Sung Joon ^a   Kang, Chang Don ^a   Park, Myoung Ok ^a   Choi, Dong Wook ^a   Kim, Tae Suk ^a   Lee, Wonho ^a   Cho, Byung Ryul ^a   Kim, Yong Hoon ^a   Lee, Bong Ki ^a   Ryu, Dong Ryeol ^a   Lee, Ji Won ^a  

^a Kangwon National University   (South Korea)

Author keywords

Adiponectin; Coronary angiography; Coronary artery disease; Insulin resistance; Nonalcoholic fatty liver disease

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREDICTION; RISK FACTOR; SCORING SYSTEM;

ADIPONECTIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; INSULIN RESISTANCE; NONALCOHOLIC FATTY LIVER DISEASE;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; SEVERITY OF ILLNESS INDEX;

EID: 84885629340     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i38.6453     Document Type: Article

References (25)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395 [PMID: 15565570 DOI: 10.1002/hep.20466]
2. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003; 98: 2042-2047 [PMID: 14499785 DOI: 10.1111/j.1572-0241.2003.07659.x]
3. Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, Kim YJ, Yoon JH, Jeong SH, Lee DH, Lee HS, Larson J, Therneau TM, Kim WR. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012; 56: 605-613 [PMID: 22271511 DOI: 10.1002/hep.25593]
4. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008; 51: 1947-1953 [PMID: 18762907 DOI: 10.1007/s00125-008-1135-4]
5. Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]. Korean J Hepatol 2008; 14: 77-88 [PMID: 18367860 DOI: 10.3350/kjhep.2008.14.1.77]
6. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-1330 [PMID: 16732016 DOI: 10.2337/dc06-0135]
7. Edens MA, Kuipers F, Stolk RP. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obes Rev 2009; 10: 412-419 [PMID: 19413701 DOI: 10.1111/j.1467-789X.2009.00594.x]
8. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007; 116: e148-e304 [PMID: 17679616 DOI: 10.1161/circulationaha.107.181940]
9. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231 [PMID: 11961152 DOI: 10.1056/NEJMra011775]
10. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A. Liver diseases and metabolic syndrome. J Gastroenterol 2008; 43: 509-518 [PMID: 18648737 DOI: 10.1007/s00535-008-2193-6]
11. Choi SY, Kim D, Kim HJ, Kang JH, Chung SJ, Park MJ, Kim YS, Kim CH, Choi SH, Kim W, Kim YJ, Yoon JH, Lee HS, Cho SH, Sung MW, Oh BH. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol 2009; 104: 1953-1960 [PMID: 19491838 DOI: 10.1038/ajg.2009.238]
12. Mirbagheri SA, Rashidi A, Abdi S, Saedi D, Abouzari M. Liver: an alarm for the heart? Liver Int 2007; 27: 891-894 [PMID: 17696926 DOI: 10.1111/j.1478-3231.2007.01531.x]
13. Arslan U, Türkoǧlu S, Balcioǧlu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis 2007; 18: 433-436 [PMID: 17700213 DOI: 10.1097/MCA.0b013e3282583c0d]
14. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32 [PMID: 15198963 DOI: 10.1161/01.CIR.0000131515.03336.f8]
15. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, Chim AM, Yu CM, Yu J, Chan FK, Sung JJ, Chan HL. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011; 60: 1721-1727 [PMID: 21602530 DOI: 10.1136/gut.2011.242016]
16. Aller R, de Luis DA, Fernandez L, Calle F, Velayos B, Olcoz JL, Izaola O, Sagrado MG, Conde R, Gonzalez JM. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig Dis Sci 2008; 53: 1088-1092 [PMID: 17934820 DOI: 10.1007/s10620-007-9981-3]
17. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541-3546 [PMID: 16306373]
18. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008; 134: 1682-1698 [PMID: 18471547 DOI: 10.1053/j.gastro.2008.02.077]
19. Wieckowska A, Zein NN, Yerian LM, Lopez AR, Mc-Cullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006; 44: 27-33 [PMID: 16799979 DOI: 10.1002/hep.21223]
20. Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007; 13: 837-844 [PMID: 17352011]
21. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-1737 [PMID: 15082700 DOI: 10.1001/jama.291.14.1730]
22. Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19: 802-812 [PMID: 23430039 DOI: 10.3748/ wjg.v19.i6.802]
23. Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012; 2012: 145754 [PMID: 22110476 DOI: 10.1155/2012/145754]
24. Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 2012; 27: 1555-1560 [PMID: 22741595 DOI: 10.1111/j.1440-1746.2012.07222.x]
25. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725 [PMID: 12404245]